Trial · NCT01123889
Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection
NCT01123889, Not applicable, Completed, Loma Linda University; results first posted 2014-02-11
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection. Trials, record NCT01123889. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01123889
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection
- NCT number
- NCT01123889
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 12 participants, actual
- Lead sponsor
- Loma Linda University
- Conditions
- Subacromial Impingement Syndrome, Partial Thickness Rotator Cuff Tear
- Interventions
- platelet rich plasma injection, corticosteroid injection
- First posted
- 2010-05-14
- Last updated
- 2014-02-11
- Results first posted
- 2014-02-11
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain and Disability of the Shoulder Through Validated Questionnaires | 6 weeks from initial injection of corticosteroid versus platelet rich plasma | Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. |
| Primary | Pain and Disability of the Shoulder Through Validated Questionnaires | 12 weeks from initial injection of corticosteroid versus platelet rich plasma | Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. |
| Primary | Pain and Disability of the Shoulder Through Validated Questionnaires | 15 minutes prior to initial injection of corticosteroid versus platelet rich plasma | Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pain and Disability of the Shoulder Through Validated Questionnaires | 6 weeks from initial injection of corticosteroid versus platelet rich plasma | units on a scale | MEAN | |
| PRIMARY | Pain and Disability of the Shoulder Through Validated Questionnaires | 12 weeks from initial injection of corticosteroid versus platelet rich plasma | units on a scale | MEAN | |
| PRIMARY | Pain and Disability of the Shoulder Through Validated Questionnaires | 15 minutes prior to initial injection of corticosteroid versus platelet rich plasma | units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pain and Disability of the Shoulder Through Validated Questionnaires | Control | 81.6 | Standard Deviation 9.4 | units on a scale | |
| Pain and Disability of the Shoulder Through Validated Questionnaires | Experimental | 70.0 | Standard Deviation 13.7 | units on a scale | |
| Pain and Disability of the Shoulder Through Validated Questionnaires | Control | 41.6 | Standard Deviation 4.7 | units on a scale | |
| Pain and Disability of the Shoulder Through Validated Questionnaires | Experimental | 86.1 | Standard Deviation 17.1 | units on a scale | |
| Pain and Disability of the Shoulder Through Validated Questionnaires | Control | 35.0 | Standard Deviation 18.9 | units on a scale | |
| Pain and Disability of the Shoulder Through Validated Questionnaires | Experimental | 43.9 | Standard Deviation 7.4 | units on a scale |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Control | 5 | |
| Overall Study | STARTED | Experimental | 7 | |
| Overall Study | COMPLETED | Control | 2 | |
| Overall Study | COMPLETED | Experimental | 6 | |
| Overall Study | NOT COMPLETED | Control | 3 | |
| Overall Study | NOT COMPLETED | Experimental | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Control | ||
| Total, all-cause mortality | Experimental | ||
| Total, other adverse events | Control | 0 | 5 |
| Total, other adverse events | Experimental | 0 | 7 |
| Total, serious adverse events | Control | 0 | 5 |
| Total, serious adverse events | Experimental | 0 | 7 |
Source ClinicalTrials.gov
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Experimental vs Control: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01123889
GET https://conductscience.org/api/trials/v1/NCT01123889/registered